Filing Flows › CorMedix (CRMD) › Stock forecast & fair value
CorMedix (CRMD) stock forecast and price target
CorMedix (CRMD) trades at $5.32. 6 analysts' median price target is $14.50 (+173%), from $12.00 to $19.00.
CorMedix's latest quarter
CorMedix, Q2 2026: revenue $102M (+156% year over year), operating margin 42.1%, net earnings $26.0M, operating cash flow $86.2M. The chart follows the revenue to costs, profit and cash.
Questions
What is the price target for CRMD stock?
The median of 6 analysts' 12-month targets is $14.50, +173% from $5.32; the range is $12.00 to $19.00. The average rating is none.
Does CorMedix usually beat earnings estimates?
It beat the consensus EPS estimate in 75% of the quarters on record.
Is CRMD stock a buy?
Filing Flows does not give advice. It shows what analysts expect, what each valuation method implies and the figures behind them, read from SEC filings, so you can judge for yourself.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.